Article Text
Letters
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
Statistics from Altmetric.com
Footnotes
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval
-
Provenance and peer review Not commissioned; externally peer reviewed.